MetLife Investment Management LLC grew its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 12.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 64,413 shares of the company's stock after purchasing an additional 6,883 shares during the period. MetLife Investment Management LLC's holdings in Ryan Specialty were worth $4,133,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of RYAN. Ossiam increased its stake in Ryan Specialty by 81.6% in the fourth quarter. Ossiam now owns 4,394 shares of the company's stock worth $282,000 after purchasing an additional 1,975 shares during the period. First Trust Advisors LP increased its stake in Ryan Specialty by 41.4% in the 4th quarter. First Trust Advisors LP now owns 548,706 shares of the company's stock worth $35,205,000 after buying an additional 160,597 shares during the period. Marshall Wace LLP lifted its holdings in Ryan Specialty by 251.2% during the 4th quarter. Marshall Wace LLP now owns 192,726 shares of the company's stock valued at $12,365,000 after buying an additional 137,853 shares in the last quarter. Zacks Investment Management boosted its position in Ryan Specialty by 2.1% in the 4th quarter. Zacks Investment Management now owns 107,937 shares of the company's stock valued at $6,925,000 after buying an additional 2,259 shares during the period. Finally, Jump Financial LLC grew its stake in Ryan Specialty by 29.2% in the 4th quarter. Jump Financial LLC now owns 31,666 shares of the company's stock worth $2,032,000 after acquiring an additional 7,159 shares in the last quarter. Institutional investors own 84.82% of the company's stock.
Insider Transactions at Ryan Specialty
In related news, Director Nicholas Dominic Cortezi sold 31,409 shares of Ryan Specialty stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the completion of the transaction, the director now directly owns 2,697 shares in the company, valued at approximately $177,031.08. This trade represents a 92.09 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Company insiders own 11.10% of the company's stock.
Ryan Specialty Stock Performance
RYAN traded down $1.13 on Tuesday, reaching $64.25. 2,025,580 shares of the stock were exchanged, compared to its average volume of 968,330. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company's 50-day moving average price is $70.35 and its 200 day moving average price is $68.88. The firm has a market capitalization of $16.83 billion, a PE ratio of 93.12, a PEG ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a fifty-two week low of $48.67 and a fifty-two week high of $77.16.
Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. As a group, sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were issued a $0.12 dividend. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.75%. The ex-dividend date was Tuesday, March 4th. Ryan Specialty's dividend payout ratio is 69.57%.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on RYAN shares. UBS Group increased their price objective on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Keefe, Bruyette & Woods cut their price target on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. TD Cowen initiated coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They issued a "buy" rating and a $89.00 price objective for the company. Barclays cut their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. Finally, Wells Fargo & Company lowered their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $75.67.
Check Out Our Latest Research Report on Ryan Specialty
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Further Reading

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report